Annual CFF
$272.50 M
+$240.80 M+759.74%
December 31, 2023
Summary
- As of February 26, 2025, BCAX annual cash flow from financing activities is $272.50 million, with the most recent change of +$240.80 million (+759.74%) on December 31, 2023.
- During the last 3 years, BCAX annual CFF has risen by +$240.80 million (+759.74%).
- BCAX annual CFF is now at all-time high.
Performance
BCAX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$334.13 M
NaN%
September 30, 2024
Summary
- As of February 26, 2025, BCAX quarterly cash flow from financing activities is $334.13 million
- BCAX quarterly CFF is now at all-time high.
Performance
BCAX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$334.13 M
NaN%
September 30, 2024
Summary
- As of February 26, 2025, BCAX TTM cash flow from financing activities is $334.13 million
- BCAX TTM CFF is now at all-time high.
Performance
BCAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BCAX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +759.7% | - | - |
| 3 y3 years | +759.7% | - | - |
| 5 y5 years | +759.7% | - | - |
BCAX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +759.7% | at high | +737.4% | at high | +737.4% |
| 5 y | 5-year | at high | +759.7% | at high | +737.4% | at high | +737.4% |
| alltime | all time | at high | +759.7% | at high | +737.4% | at high | +737.4% |
Bicara Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $334.13 M(+737.4%) | $334.13 M(+737.4%) |
| Dec 2023 | $272.50 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $39.90 M | $39.90 M |
| Dec 2022 | $31.70 M | - | - |
FAQ
- What is Bicara Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Bicara Therapeutics?
- What is Bicara Therapeutics annual CFF year-on-year change?
- What is Bicara Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bicara Therapeutics?
- What is Bicara Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bicara Therapeutics?
What is Bicara Therapeutics annual cash flow from financing activities?
The current annual CFF of BCAX is $272.50 M
What is the all time high annual CFF for Bicara Therapeutics?
Bicara Therapeutics all-time high annual cash flow from financing activities is $272.50 M
What is Bicara Therapeutics annual CFF year-on-year change?
Over the past year, BCAX annual cash flow from financing activities has changed by +$240.80 M (+759.74%)
What is Bicara Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of BCAX is $334.13 M
What is the all time high quarterly CFF for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly cash flow from financing activities is $334.13 M
What is Bicara Therapeutics TTM cash flow from financing activities?
The current TTM CFF of BCAX is $334.13 M
What is the all time high TTM CFF for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM cash flow from financing activities is $334.13 M